Literature DB >> 12431131

Diabetes insipidus in children: pathophysiology, diagnosis and management.

Tim Cheetham1, Peter H Baylis.   

Abstract

In diabetes insipidus, the amount of water ingested and the quantity and concentration of urine produced needs to be carefully regulated if fluid volume and osmolality are to be maintained within the normal range. One of the principal mechanisms controlling urine output is vasopressin which is released from the posterior pituitary gland and enhances water reabsorption from the renal collecting duct. In diabetes insipidus, the excessive production of dilute urine, and the causes of this clinical picture can be divided into three main groups: the first is primary polydipsia where the amount of fluid ingested is inappropriately large; the second group is cranial diabetes insipidus where the production of vasopressin is abnormally low; and, the third group is nephrogenic diabetes insipidus where the kidney response to vasopressin is impaired. The history and examination may suggest an underlying explanation for diabetes insipidus but a range of baseline and more extensive investigations may be required before a diagnosis can be reached. These investigations are not without risk, and the results need to be interpreted carefully because children do not always segregate neatly into a particular diagnostic category on the basis of one test alone. Children with cranial diabetes insipidus typically respond to arginine vasopressin or its manufactured analogue, desmopressin, with an increase in urine osmolality and an associated reduction in urine output. Such children usually require neuroimaging to look for evidence of evolving CNS pathology, such as an intracranial tumour. Vasopressin "replacement" with desmopressin is the treatment of choice in patients with cranial diabetes insipidus although extreme caution is required when treating babies or small children because of the danger of fluid overload. Abnormal production of other pituitary hormones in children with CNS disease can also influence fluid balance. Nephrogenic diabetes insipidus can be due to abnormal electrolyte concentrations, therefore these should be measured as part of the initial assessment. In a small number of children the defect is a primary abnormality of the vasopressin receptor or one of the water channel proteins (aquaporins) involved in water transport. The treatment of these patients is difficult and typically involves therapy with a diuretic such as chlorothiazide, as well as indomethacin. These agents enhance urine osmolality by their effect on circulating volume and renal solute and water handling. The fluid intake of most young children with primary polydipsia can be safely reduced to a more appropriate level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431131     DOI: 10.2165/00128072-200204120-00003

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  48 in total

1.  Familial neurohypophysial diabetes insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone.

Authors:  M Nijenhuis; E L van den Akker; R Zalm; A A Franken; A P Abbes; H Engel; D de Wied; J P Burbach
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

2.  Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents.

Authors:  S L Mootha; A J Barkovich; M M Grumbach; M S Edwards; S E Gitelman; S L Kaplan; F A Conte
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

3.  Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP).

Authors:  O Koskimies; J Pylkkänen; J Vilska
Journal:  Acta Paediatr Scand       Date:  1984-01

4.  Hypertonic saline test for the investigation of posterior pituitary function.

Authors:  A Mohn; C L Acerini; T D Cheetham; S L Lightman; D B Dunger
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

5.  Oral desmopressin treatment of central diabetes insipidus in children.

Authors:  E M Boulgourdjian; A S Martínez; M G Ropelato; J J Heinrich; C Bergadá
Journal:  Acta Paediatr       Date:  1997-11       Impact factor: 2.299

6.  Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation.

Authors:  Z Hochberg; A Van Lieburg; L Even; B Brenner; N Lanir; B A Van Oost; N V Knoers
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

7.  Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.

Authors:  J Leger; A Velasquez; C Garel; M Hassan; P Czernichow
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

8.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

9.  Oral desmopressin in neonatal diabetes insipidus.

Authors:  S M Stick; P R Betts
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

10.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.

Authors:  T M Strom; K Hörtnagel; S Hofmann; F Gekeler; C Scharfe; W Rabl; K D Gerbitz; T Meitinger
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

View more
  9 in total

1.  How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications.

Authors:  Dean Elbe; Robert Savage
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-02

2.  Clinical, hormonal and imaging findings in 27 children with central diabetes insipidus.

Authors:  Julie De Buyst; Guy Massa; Catherine Christophe; Sylvie Tenoutasse; Claudine Heinrichs
Journal:  Eur J Pediatr       Date:  2006-08-31       Impact factor: 3.183

Review 3.  Brief review and commentary: diagnosis of pediatric pituitary disorders.

Authors:  John Ching; Phillip D K Lee
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

4.  Central diabetes insipidus and adipsia due to astrocytoma: diagnosis and management.

Authors:  Imad Modawi; Geoffrey R Barger; Noreen F Rossi
Journal:  CEN Case Rep       Date:  2012-08-09

5.  Post-operative diabetes insipidus after endoscopic transsphenoidal surgery.

Authors:  Matthew Schreckinger; Blake Walker; Jordan Knepper; Mark Hornyak; David Hong; Jung-Min Kim; Adam Folbe; Murali Guthikonda; Sandeep Mittal; Nicholas J Szerlip
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

6.  Rare neonatal diabetes insipidus and associated late risks: case report.

Authors:  Maximiliano Francisco Rivas-Crespo; Lorena Miñones-Suárez; Susana Serrano G-Gallarza
Journal:  BMC Pediatr       Date:  2012-05-28       Impact factor: 2.125

7.  Endoplasmic reticulum stress induces apoptosis of arginine vasopressin neurons in central diabetes insipidus via PI3K/Akt pathway.

Authors:  Ming-Feng Zhou; Zhan-Peng Feng; Yi-Chao Ou; Jun-Jie Peng; Kai Li; Hao-Dong Gong; Bing-Hui Qiu; Ya-Wei Liu; Yong-Jia Wang; Song-Tao Qi
Journal:  CNS Neurosci Ther       Date:  2019-01-24       Impact factor: 5.243

8.  Pituitary Morphology and Function in 43 Children with Central Diabetes Insipidus.

Authors:  Wendong Liu; Limin Wang; Minghua Liu; Guimei Li
Journal:  Int J Endocrinol       Date:  2016-03-29       Impact factor: 3.257

Review 9.  Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.

Authors:  Mladena Glavaš; Agata Gitlin-Domagalska; Dawid Dębowski; Natalia Ptaszyńska; Anna Łęgowska; Krzysztof Rolka
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.